Congress orders study of opioid-exposed infants, Medicaid gaps
H.R. 6220 — MIRACLE Act of 2025 · Filed by Dan Newhouse (R-WA) · 3 cosponsors · Introduced Nov 20, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study neonatal abstinence syndrome (NAS)—a condition affecting infants born to mothers using opioids—and report findings to Congress within 3 years. The study will examine how common NAS is among Medicaid beneficiaries, what barriers exist to collecting accurate data, and what services are available to affected infants under state Medicaid plans. The report will be published publicly.
Why we flagged it
The bill's sole operative mechanism is a directive to study and report on neonatal abstinence syndrome prevalence and Medicaid service availability. It creates no new programs, funding streams, or regulatory changes—only a data-gathering and transparency requirement.
What the text implies
- The 3-year timeline may delay policy response to a known crisis; no interim reporting or milestone is required.
- Study scope is limited to Medicaid beneficiaries; private insurance and uninsured populations are excluded from the mandate, potentially obscuring the full scope of NAS.
The full analysis lists 4 implications of this text.
Who it affects
The bill creates a public health information mandate with no restrictions on citizens' rights or access. It generates transparency on a serious public health crisis (opioid-exposed infants) and identifies service gaps in Medicaid coverage, enabling evidence-based policy responses.